Salem Investment Counselors’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$814K Sell
10,406
-150
-1% -$11.7K 0.03% 229
2025
Q1
$765K Buy
10,556
+940
+10% +$68.1K 0.03% 225
2024
Q4
$712K Sell
9,616
-800
-8% -$59.2K 0.02% 237
2024
Q3
$687K Buy
10,416
+99
+1% +$6.53K 0.02% 237
2024
Q2
$953K Hold
10,317
0.03% 202
2024
Q1
$986K Buy
10,317
+1,875
+22% +$179K 0.03% 202
2023
Q4
$644K Sell
8,442
-1,235
-13% -$94.2K 0.02% 226
2023
Q3
$670K Buy
9,677
+3,725
+63% +$258K 0.03% 208
2023
Q2
$561K Hold
5,952
0.02% 226
2023
Q1
$492K Sell
5,952
-700
-11% -$57.9K 0.02% 239
2022
Q4
$496K Sell
6,652
-1,650
-20% -$123K 0.02% 240
2022
Q3
$686K Hold
8,302
0.03% 203
2022
Q2
$789K Sell
8,302
-6,106
-42% -$580K 0.04% 197
2022
Q1
$1.7M Sell
14,408
-45
-0.3% -$5.3K 0.07% 148
2021
Q4
$1.87M Buy
14,453
+460
+3% +$59.6K 0.07% 142
2021
Q3
$1.58M Buy
13,993
+3,210
+30% +$363K 0.09% 149
2021
Q2
$1.12M Buy
10,783
+300
+3% +$31.1K 0.06% 167
2021
Q1
$877K Buy
10,483
+4,213
+67% +$352K 0.05% 168
2020
Q4
$572K Buy
6,270
+400
+7% +$36.5K 0.04% 189
2020
Q3
$469K Buy
5,870
+305
+5% +$24.4K 0.04% 189
2020
Q2
$385K Buy
5,565
+1,125
+25% +$77.8K 0.03% 193
2020
Q1
$279K Hold
4,440
0.03% 205
2019
Q4
$345K Buy
4,440
+390
+10% +$30.3K 0.03% 214
2019
Q3
$297K Hold
4,050
0.03% 217
2019
Q2
$249K Hold
4,050
0.02% 235
2019
Q1
$235K Hold
4,050
0.02% 185
2018
Q4
$207K Hold
4,050
0.03% 180
2018
Q3
$235K Hold
4,050
0.02% 185
2018
Q2
$197K Buy
4,050
+390
+11% +$19K 0.02% 193
2018
Q1
$166K Hold
3,660
0.02% 198
2017
Q4
$138K Sell
3,660
-597
-14% -$22.5K 0.02% 220
2017
Q3
$156K Hold
4,257
0.02% 209
2017
Q2
$168K Buy
4,257
+597
+16% +$23.6K 0.02% 210
2017
Q1
$115K Sell
3,660
-8,280
-69% -$260K 0.01% 284
2016
Q4
$373K Hold
11,940
0.04% 199
2016
Q3
$4.8K Buy
+11,940
New +$4.8K 0.06% 162